A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis ERRATUMThe Pediatric Infectious Disease Journal: November 2018 - Volume 37 - Issue 11 - p 1198 doi: 10.1097/INF.0000000000002209 Erratum Free Article OutlineOutline Article MetricsMetrics REFERENCE Supplemental Digital Content In the article on page 992, volume 37, issue 10, the acknowledgments should include: “Astellas and authors thank the participating investigators and staff for their enormous contributions for this clinical trial. A list of centers that contributed to the study is available at http://links.lww.com/INF/D304.”Back to Top | Article Outline REFERENCE Benjamin DK Jr, Kaufman DA, Hope WW, et alA phase 3 study of micafungin versus amphotericin B deoxycholate in infants with invasive candidiasis. Pediatr Infect Dis J. 2018;37:992–998. View Full Text | PubMed | CrossRef Supplemental Digital Content INF_37_10_2018_09_26_BENJAMIN_217-201_SDC2.pdf; [PDF] (89 KB) Back to Top | Article OutlineCopyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.